Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease Meta-Analysis and Meta-Regression of Randomized Trials

被引:56
|
作者
Pasceri, Vincenzo [1 ,2 ]
Patti, Giuseppe [3 ]
Pelliccia, Francesco [2 ]
Gaudio, Carlo [2 ]
Speciale, Giulio [1 ,2 ]
Mehran, Roxana [4 ,5 ]
Dangas, George D. [4 ,5 ]
机构
[1] San Filippo Neri Hosp, Via G Martinotti 20, I-00135 Rome, Italy
[2] Univ Roma La Sapienza, Rome, Italy
[3] Campus Biomed Univ, Rome, Italy
[4] Icahn Sch Med Mt Sinai, Zena & Michael Wiener Cardiovasc Inst, New York, NY 10029 USA
[5] Cardiovasc Res Fdn, New York, NY USA
关键词
coronary interventions; meta-analysis; meta-regression; multivessel disease; ST-segment elevation myocardial infarction; ST-SEGMENT ELEVATION; CULPRIT-ONLY REVASCULARIZATION; ARTERY-DISEASE; DIABETIC-PATIENTS; VESSEL; ANGIOPLASTY; MANAGEMENT; PAIRWISE; FOLLOW; LESION;
D O I
10.1016/j.jcin.2018.02.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to compare complete revascularization with a culprit-only strategy in patients presenting with ST-segment elevation myocardial infarction (MI) and multivessel disease by a meta-analysis of randomized trials. BACKGROUND Although several trials have compared complete with culprit-only revascularization in ST-segment elevation MI, it remains unclear whether complete revascularization may lead to improvement in hard endpoints (death and MI). METHODS Randomized trials comparing complete revascularization with culprit-only revascularization in patients with ST-segment elevation MI without cardiogenic shock were identified by a systematic search of published research. Random-effects meta-analysis was performed, comparing clinical outcomes in the 2 groups. RESULTS Eleven trials were identified, including a total of 3,561 patients. Compared with a culprit-only strategy, complete revascularization significantly reduced risk for death or MI (relative risk [RR]: 0.76; 95% confidence interval [CI]: 0.58 to 0.99; p = 0.04). Meta-regression showed that performing complete revascularization at the time of primary percutaneous coronary intervention (PCI) was associated with better outcomes (p = 0.016). The 6 trials performing complete revascularization during primary PCI (immediate revascularization) were associated with a significant reduction in risk for both total mortality (RR: 0.62; 95% CI: 0.39 to 0.97; p = 0.03) and MI (RR: 0.40; 95% CI: 0.25 to 0.66; p < 0.001), whereas the 5 trials performing only staged revascularization did not show any significant benefit in either total mortality (RR: 1.02; 95% CI: 0.65 to 1.62; p = 0.87) or MI (RR: 1.04; 95% CI: 0.48 to 1.68; p = 0.86). CONCLUSIONS When feasible, complete revascularization with PCI can significantly reduce the combined endpoint of death and MI. Complete revascularization performed during primary PCI was also associated with significant reductions in both total mortality and MI, whereas staged revascularization did not improve these outcomes. (c) 2018 by the American College of Cardiology Foundation.
引用
收藏
页码:833 / 843
页数:11
相关论文
共 50 条
  • [41] Outcomes of complete versus incomplete myocardial revascularization in multivessel coronary artery disease: a meta-analysis of randomized and observational studies
    Ricci, F.
    Zimarino, M.
    Corazzini, A.
    Romanello, M.
    Cicchitti, V.
    De Caterina, R.
    EUROPEAN HEART JOURNAL, 2012, 33 : 546 - 546
  • [42] Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials
    Vaidya, Satyanarayana R.
    Qamar, Arman
    Arora, Sameer
    Devarapally, Santhosh R.
    Kondur, Ashok
    Kaul, Prashant
    CORONARY ARTERY DISEASE, 2018, 29 (02) : 151 - 160
  • [43] Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease
    Bangalore, Sripal
    Toklu, Bora
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (05): : 529 - 536
  • [44] Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials
    Elgendy, Islam Y.
    Wen, Xuerong
    Mahmoud, Ahmed
    Bavry, Anthony A.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (04) : 501 - 505
  • [45] Intravenous β-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials
    Elgendy, Islam Y.
    Elgendy, Akram Y.
    Mahmoud, Ahmed N.
    Mansoor, Hend
    Mojadidi, Mohammad K.
    Bavry, Anthony A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 891 - 897
  • [46] Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials
    Xu, Li
    Wang, Lefeng
    Li, Kuibao
    Zhang, Zhiyong
    Sun, Hao
    Yang, Xinchun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1389 - 1400
  • [47] Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials
    Li, Jun
    Zhang, Ling
    Lu, Aixia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2825 - 2826
  • [49] Complete Revascularization for Multivessel Disease ST Elevation Myocardial Infarction: Insights From an Updated Meta-Analysis
    Kundu, Amartya
    Sardar, Partha
    Chatterjee, Saurav
    Gin, Jay
    Mukherjee, Debabrata
    CIRCULATION, 2015, 132
  • [50] Timing of Percutaneous Coronary Intervention for Non-infarct-related Coronary Artery in Patients with Acute Myocardial Infarction and Multivessel Disease: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
    Toyota, Toshiaki
    Nakamura, Kanna
    Sano, Madoka
    Azumi, Yuta
    Hideyuki, Hayashi
    Murai, Ryosuke
    Ooka, Junichi
    Sasaki, Yasuhiro
    Taniguchi, Tomohiko
    Kim, Kitae
    Kobori, Atsushi
    Ehara, Natsuhiko
    Kinoshita, Makoto
    Furukawa, Yutaka
    CIRCULATION, 2024, 150